E-Cigarette Flavorings, Additives Increase Inflammation and Impair Lung Function, Study Finds
Short-term e-cigarette use causes as much or more damage as conventional cigarettes
Rockville, Md. (October 11, 2018)—Flavoring and additive ingredients in e-cigarettes may increase inflammation and impair lung function, according to new research. The study, published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology, also found that short-term exposure to e-cigarettes was enough to cause lung inflammation similar or worse than that seen in traditional cigarette use. The research was chosen as an APSselect article for October.
E-cigarettes, popular battery-powered devices that simulate the act of smoking a traditional cigarette, dispense a vapor derived from liquid chemicals in a refillable cartridge. The refills typically contain propylene glycol, nicotine and often flavorings. Propylene glycol—a colorless, odorless food additive—is found in numerous processed food and beverages; it is also used as a solvent in a number pharmaceuticals. E-cigarette devices and refills are not well regulated, and the long-term health effects of e-cigarette use are not widely known.
Researchers studied several groups of mice that received whole-body exposure to varying chemical combinations four times each day. Each exposure session was separated by 30-minute smoke-free intervals.
- One group was exposed to cigarette smoke (“cigarette”);
- One group was exposed to e-cigarette vapor containing propylene glycol and vegetable glycerol, an odorless liquid derived from plant oils (“propylene”);
- One group was exposed to e-cigarette vapor containing propylene glycol and nicotine (“propylene + nicotine”) and
- One group was exposed to e-cigarette vapor containing propylene glycol, nicotine and tobacco flavoring (“flavoring”).
The cigarette and e-cigarette groups were compared with a control group that was exposed to medical-grade air. Some of the animals in each group were exposed to short-term cigarette smoke or e-cigarette vapor (three days), while others were exposed for a longer term (four weeks).
The research team found an increase in markers of inflammation, mucus production and altered lung function in the propylene, propylene + nicotine and flavoring groups after three days. However, the propylene group showed fewer negative effects with long-term exposure, suggesting the additive alone elicits only a temporary irritation that eventually subsides with continued use. In addition, two inflammation-producing proteins became elevated only in the flavoring group, suggesting that some of the many flavoring components on the market may not be safe for even short-term use.
The condition of the e-cigarette groups in comparison with the cigarette group surprised the researchers. The level of oxidative stress—stress at a cellular level—in the flavoring group was equal to or higher than that of the cigarette group. However, respiratory mechanics were adversely affected only in mice exposed to cigarette smoke and not to e-cigarette vapor after prolonged treatment. “The observed detrimental effects in the lung upon [e-cigarette] vapor exposure in animal models highlight the need for further investigation of safety and toxicity of these rapidly expanding devices worldwide,” the researchers wrote.
Read the full article, “Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice,” published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology. It is highlighted as one of this month’s “best of the best” as part of the American Physiological Society’s APSselect program. Read all of this month’s selected research articles.
NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or 301-634-7314. Find more research highlights in the APS Press Room.
Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.